FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $369,899 | -58.5% | 174,481 | -6.9% | 0.00% | -50.0% |
Q2 2023 | $892,383 | -9.0% | 187,476 | +8.9% | 0.00% | 0.0% |
Q1 2023 | $980,911 | +18279.4% | 172,090 | +32431.2% | 0.00% | – |
Q4 2022 | $5,337 | -51.5% | 529 | 0.0% | 0.00% | – |
Q3 2022 | $11,000 | -15.4% | 529 | 0.0% | 0.00% | – |
Q2 2022 | $13,000 | -35.0% | 529 | 0.0% | 0.00% | – |
Q1 2022 | $20,000 | -33.3% | 529 | 0.0% | 0.00% | – |
Q4 2021 | $30,000 | -3.2% | 529 | 0.0% | 0.00% | – |
Q3 2021 | $31,000 | -92.7% | 529 | -89.3% | 0.00% | -100.0% |
Q2 2021 | $427,000 | -86.6% | 4,924 | -87.3% | 0.00% | -83.3% |
Q1 2021 | $3,192,000 | -41.2% | 38,736 | -35.1% | 0.01% | -45.5% |
Q4 2020 | $5,426,000 | +99.0% | 59,648 | -12.6% | 0.01% | +83.3% |
Q3 2020 | $2,726,000 | +16.6% | 68,251 | 0.0% | 0.01% | +20.0% |
Q2 2020 | $2,338,000 | +6.2% | 68,251 | -31.1% | 0.01% | -16.7% |
Q1 2020 | $2,201,000 | -28.5% | 99,078 | -37.0% | 0.01% | 0.0% |
Q4 2019 | $3,078,000 | +118.6% | 157,358 | +73.5% | 0.01% | +100.0% |
Q3 2019 | $1,408,000 | +501.7% | 90,677 | +53.3% | 0.00% | – |
Q3 2017 | $234,000 | – | 59,168 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |